Skip to main content

Table 1 Baseline demographic and clinical characteristics between patients in the AC and No AC group

From: Does adjuvant chemotherapy result in poorer health-related quality of life among colorectal cancer patients? A longitudinal multisite observational study in Singapore

 

AC Group (N = 102)

No AC Group (N = 149)

p

Age, years, mean (SD)

64.50 (10.60)

70.21 (11.75)

 < 0.05*

Categorical age, N (%)

 Below 65 years

42 (41.18)

41 (27.52)

 

 65 years and above

60 (58.82)

108 (72.48)

 < 0.05*

Race, N (%)

 Chinese

86 (84.31)

126 (85.71)

 

 Malay

11 (10.78)

13 (8.84)

 

 Indian

4 (3.92)

6 (4.08)

 

 Others

1 (0.98)

2 (1.36)

0.96

Sex, N (%)

 Female

41 (40.59)

61 (42.07)

 

 Male

60 (59.41)

84 (57.93)

0.82

Tumour site, N (%)

 Colon

69 (67.65)

100 (67.11)

 

 Rectal

33 (32.35)

49 (32.89)

0.93

Type of surgery, N (%)

 Laparoscopic

76 (80.85)

70 (70.71)

 

 Open

11 (11.70)

24 (24.24)

 

 Laparoscopic converted to open

7 (7.45)

5 (5.05)

0.07

Stoma created N (%)

 No

63 (61.76)

79 (60.31)

 

 Yes

39 (38.24)

52 (39.69)

0.82

Stage, N (%)

 I

3 (2.94)

34 (25.56)

 

 II

32 (31.37)

47 (35.34)

 

 III

54 (52.94)

25 (18.80)

 

 IV

12 (11.76)

20 (15.04)

 

 Unknown

1 (0.98)

7 (5.26)

 < 0.05*

ASA classification, N (%)

 I

3 (3.09)

2 (1.94)

 

 II

77 (79.38)

75 (72.82)

 

 III

17 (17.53)

24 (23.30)

 

 IV

0 (0.00)

2 (1.94)

0.41

 Intraoperative estimated blood loss, ml, mean (SD)

176.47 (257.28)

112.86 (101.74)

0.14

 CCI, mean (SD)

8.22 (12.86)

9.05 (14.36)

0.67

 Postoperative length of stay, days, mean (SD)

8.11 (5.32)

10.37 (15.69)

0.18

Readmission within 30 days post-surgery

 No

91 (90.10)

114 (93.44)

 

 Yes

10 (9.90)

8 (6.56)

0.36

  1. * represents p < 0.05